Insider Transactions in Q2 2021 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
4,375
-7.78%
|
$170,625
$39.75 P/Share
|
|
Jun 23
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+7.22%
|
$105,000
$24.69 P/Share
|
|
Jun 08
2021
|
Karin Eastham Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+50.0%
|
-
|
|
Jun 08
2021
|
John L Bishop Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+50.0%
|
-
|
|
Jun 08
2021
|
Evan/ Fa Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+18.38%
|
-
|
|
Jun 08
2021
|
Jens Holstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+44.86%
|
-
|
|
Jun 08
2021
|
Kevin K Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+50.0%
|
-
|
|
Jun 08
2021
|
Robert S Epstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+50.0%
|
-
|
|
Jun 04
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
9,081
-5.2%
|
$308,754
$34.28 P/Share
|
|
Jun 04
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,156
+6.47%
|
$106,028
$13.1 P/Share
|
|
Jun 03
2021
|
Jens Holstein Director |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$70,000
$35.19 P/Share
|
|
Jun 02
2021
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,288
-1.19%
|
$82,368
$36.07 P/Share
|
|
Jun 02
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-1.7%
|
$32,832
$36.07 P/Share
|
|
Jun 01
2021
|
Marc Stapley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,807
+50.0%
|
-
|
|
May 17
2021
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,065
+6.83%
|
$70,325
$5.61 P/Share
|
|
May 17
2021
|
Beverly Jane Alley VP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
5,500
+29.73%
|
-
|
|
May 03
2021
|
Karin Eastham Director |
SELL
Open market or private sale
|
Indirect |
4,427
-12.04%
|
$216,923
$49.01 P/Share
|